19 June 2013
Keywords: supergen, leukemia, drug, cleared, usa, been, granted
Article | 22 November 2001
SuperGen has been granted approval by the US Food and DrugAdministration to market its oncology drug daunorubicin as a treatment
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 November 2001
2 August 2001
18 June 2013
© 2013 thepharmaletter.com